Emerging Roles of C-C Motif Ligand 11 (CCL11) in Cancers and Liver Diseases: Mechanisms and Therapeutic Implications

Int J Mol Sci. 2025 May 13;26(10):4662. doi: 10.3390/ijms26104662.

Abstract

C-C motif ligand 11 (CCL11) is a multifunctional chemokine that regulates immunity, angiogenesis, and tissue remodeling. In addition to its allergic inflammation role, CCL11 exhibits context-dependent dual functions in relation to cancer progression. In liver diseases, it mediates injury, fibrosis, and inflammation while serving as a disease biomarker. This review systematically examines CCL11-receptor interactions and their immunomodulatory mechanisms in cancers and hepatic pathologies. We highlight CCL11's therapeutic potential as both a prognostic marker and immunotherapeutic target. By integrating molecular and clinical insights, this work advances the understanding of CCL11's pathophysiological roles and facilitates targeted therapy development.

Keywords: cancer; chemokine CCL11; inflammation; liver disease; therapeutic target.

Publication types

  • Review

MeSH terms

  • Animals
  • Chemokine CCL11* / genetics
  • Chemokine CCL11* / metabolism
  • Humans
  • Liver Diseases* / immunology
  • Liver Diseases* / metabolism
  • Liver Diseases* / pathology
  • Liver Diseases* / therapy
  • Neoplasms* / immunology
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Neoplasms* / therapy

Substances

  • Chemokine CCL11